Toxicology 307 (2013) 74–88
Contents lists available at SciVerse ScienceDirect
Toxicology
j ournal homepage: www.elsevier.com/locate/toxicol
Persistent organochlorinated pesticides and mechanisms of their toxicity
a,b,∗ a a c
Ezra J. Mrema , Federico M. Rubino , Gabri Brambilla , Angelo Moretto ,
d a
Aristidis M. Tsatsakis , Claudio Colosio
a
Department of Health Sciences of the University of Milan, International Centre for Rural Health of the Occupational Health Unit of the University Hospital San Paolo, and Laboratory
for Analytical Toxicology and Metabolomics, Via San Vigilio 43, 20142, Milan, Italy
b
Department of Environmental and Occupational Health, Muhimbili University of Health and Allied Sciences, P.O. Box 65015, Dar es Salaam, Tanzania
c
Department of Biomedical and Clinical Sciences, Luigi Sacco of the University of Milan and International Centre for Pesticides and Health Risk Prevention (ICPS) of the University
Hospital Luigi Sacco, Via GB Grassi 74, 20157 Milan, Italy
d
Centre of Toxicology Sciences and Research, Division of Morphology, Medical School, University of Crete, Voutes, Heraklion, 71003 Crete, Greece
a r a
t i c l e i n f o b s t r a c t
Article history: Persistent organic pollutants comprised of organic chemicals like polychlorinated biphenyls, dibenzo-p-
Received 22 October 2012
dioxins, dibenzofurans and organochlorinated pesticides which have many characteristics in common.
Received in revised form
Once released in the environment they resist physical, biological, chemical and photochemical breakdown
24 November 2012
processes and thus persist in the environment. They are subject to long transboundary air pollution trans-
Accepted 27 November 2012
port. They accumulate in the food chain due to their lipophilicity, bioaccumulation and biomagnification
Available online 3 December 2012
properties. Human exposure occurs through inhalation of air, ingestion of food and skin contact. Because
most of them bioaccumulate and remain preferentially in fat, their long-term effects are still a matter of
Keywords:
public health concern. They are condemned for health adverse effects such as cancer, reproductive defects,
Human exposure
neurobehavioral abnormalities, endocrine and immunological toxicity. These effects can be elicited via a
Adverse health effect
Organochlorinated pesticides number of mechanisms among others include disruption of endocrine system, oxidation stress and epi-
Mechanisms of action genetic. However most of the mechanisms are not clear thus a number of studies are ongoing trying to
elucidate them. In this review, the underlying possible mechanisms of action and their possible roles in
adverse developmental and reproductive processes are discussed and where possible a linkage is made to
some existing epidemiological data. Both genomic and nongenomic pathways are used to describe these
effects. Understanding of these mechanisms will enable development of strategies to protect the pub-
lic by reducing these adverse effects. This review is limited to persistent organochlorinated pesticides
(OCPs) such as dichlorodiphenyltrichloroethane (DDT) and its metabolites, hexachlorobenzene (HCB),
beta-hexachlorocyclohexane (-HCH) and endosulfan. © 2012 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Persistent organochlorinated pesticides are a structurally het-
erogeneous class of organic compounds composed primarily of
•
Abbreviations: NO, nitrogen oxide radical; 16␣-OHE, 16␣-hydroxyestrone;
carbon, hydrogen and several chlorine atoms per molecule. They
2-OHE, 2-hydroxyestrone; 6 CpG, Cytosine Guanine base pair; DDT,
share similar properties with other persistent organic pollutants
dichlorodiphenyltrichloroethane; GABAA, gamma butyric acid type A
• (POPs) such as polychlorinated biphenyls (PCBs) and polychlori-
Receptor; HCB, hexachlorobenzene; HO , hydroxyl radical; o,p -DDD,
1,1-dichloro-2-(o-chlorophenyl)-2-(p chlorophenyl)ethane; o,p -DDE, nated dibenzo-p-dioxins/furans (PCDDs/Fs). Once released in the
1,1-dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethylene; o,p -DDT, 1,1,1- environment, they break down very slowly in air, water, soil and
•−
trichloro-2-(o-chlorophenyl)-2-(p chlorophenyl)-ethane; O2 , superoxide
in living organisms and are thus subject to long trans-boundary
radical; p,p -DDD, 1,1-dichloro-2, 2-bis (4-chlorophenyl)ethane; p,p -DDE,
air pollution (LTAP) transport where they are carried over long dis-
1,1-dichloro-2,2-bis(p-chlorophenyl)-ethylene; p,p -DDT, 1,1,1-trichloro-
tances via the atmospheric transport and human activities. Even the
2,2-bis(p-chlorophenyl) ethane; PCBs, polychlorinated biphenyls; PCDDs,
polychlorinated dibenzo-p-dioxins; PCDFs, polychlorinated dibenzofurans; PI3K, body burden of the flocks of migratory birds is a sizeable contribu-
phosphatidylinositol 3-kinase; TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; -HCH,
tion to LTAP (WHO, 2003). As OCPs bio-magnify through the food
beta-hexachlorocyclohexane.
∗ chain, consumers of food of animal origin such as fish, meat, milk
Corresponding author at: Department of Health Sciences of the University of
and dairy products end up with high levels of exposure and due
Milan, Via San Vigilio 43, 20142 Milan, Italy. Tel.: +39 02 81843469;
to slow biodegradation, OCPs accumulate in the body: for example
fax: +39 02 49538671; mobile: +39 327 2262702.
E-mail addresses: [email protected], [email protected] (E.J. Mrema). DDT can remain in the body for 50 years, lifelong sequestrated into
0300-483X/$ – see front matter © 2012 Elsevier Ireland Ltd. All rights reserved. http://dx.doi.org/10.1016/j.tox.2012.11.015
E.J. Mrema et al. / Toxicology 307 (2013) 74–88 75
the soft tissue compartments (mainly the adipose tissues), from 2. Mechanisms of OCPs toxicity
which they partition to the bloodstream into plasma or serum lipids
and are actively secreted into breast milk as the main elimination 2.1. Endocrine activity
pathway in mammals.
Human exposure begins during early prenatal and continues The endocrine system controls, balances and produces hor-
during the breast-feeding neonatal periods, which are critical mones and modulates their actions in the body through a network
stages for the development and differentiation of sensitive body of activation and repression pathways at multiple levels of synthe-
organs and systems. In fact, these chemicals cross the placenta to sis, secretion, transport, binding, action or elimination of natural
the foetus and are secreted into breast milk (Perera et al., 2005). hormones. Steroid hormones are involved in cell development,
In adults the dietary exposure route accounts for more than 90% metabolism, protein synthesis, behavior, reproduction and devel-
of total organochlorine compounds (OCs) burden for the general opment. These responses are elicited through binding of hormones
population, while workers are exposed mainly through inhalation to their specific receptors such as nuclear receptors (NRs). Among
and skin contact. OCs are rapidly absorbed in the small intestine the members of NRs are estrogen receptors (ERs), androgen
and enter circulatory system where they are distributed throughout receptor (AR), progesterone receptor (PR), glucocorticoid receptor
the body and accumulate in body tissues with high lipid contents, (GR), constitutive androstane receptor (CAR), rodent pregname X
with a continuous exchange between blood and tissues. As such receptor (PXR), mineralocorticoid receptor and thyroid hormone
these chemicals have been detected in human tissues such as receptors (TRs). Aromatic hydrocarbon receptor (AhR) is a key reg-
blood (whole blood, cord blood, serum and plasma), adipose tis- ulator of the cellular response to xenobiotic exposure (Swedenborg
sues (in autopsies and living subjects), breast milk, muscles and hair et al., 2009). NRs and AhR are involved in the induction of xenobiotic
(Appenzeller and Tsatsakis, 2012; Covaci et al., 2002; Dewailly et al., metabolizing enzymes.
1999; Jakszyn et al., 2009; Mrema et al., 2011; Rappolt and Hale, In the absence of ligands NRs and AhR stay in the cytoplasm or
1968; Tsang et al., 2011; Tsatsakis and Tutudaki, 2004; Tsatsakis in the cell nucleus in a complex form (Picard, 2006). In the presence
et al., 1998, 2008; Tutudaki et al., 2003). of ligands, receptor-ligand binding occurs, followed by translo-
Exposure to these persistent chemicals has been associated with cation of NRs/AhR to the nucleus. In the nucleus, a complex of
health effects including cancer (Aronson et al., 2000; Cohn et al., aryl receptor nuclear translocator (ARNT) protein and co-activators
2007; Mathur et al., 2002; Recio-Vega et al., 2011), reproductive is formed. The complex binds to the specific AhR-DNA recogni-
defects (Nicolopoulou and Stamanti, 2001) and behavioral changes tion site and finally induces transcription of target genes. The
(Zala and Penn, 2004). These effects are believed to be related to ligand binding triggers conformational changes that lead to dissoci-
their ability to disrupt the functions of certain hormones, enzymes, ation of the repressive complex, the recruitment of transcriptional
growth factors, neurotransmitters and to induce key genes involved co-activators and receptor dimerization (Hankinson, 2005). NRs
in metabolism of steroids and xenobiotics (Gourounti et al., 2008). homodimerize or heterodimerize with retinoid X receptor and AhR
The mechanism of action involves toxicokinetic and toxicody- dimerizes with ARNT leading to gene transcription of NR or AhR
namic processes, at several levels between chemical exposure and target genes (Claessens and Gewirth, 2004; Swanson, 2002). NRs
the endpoints at individual level. Variation within humans can control transcription through binding to promoter regions of DNA.
affect the endpoint at any toxicodynamic and/or toxicokinetic steps Several chlorine atoms in the molecular structures of OCPs
(Mortensen and Euling, in press). Direct, non/genomic mechanisms impart their highly lipophilic character and fairly rigid confor-
of toxicity involve perturbation of the homeostatic redox level(s) of mation (Fig. 2). The chlorine atoms are poorly reactive towards
biological compartments (oxidative stress) and consequent cellular nucleophilic displacement and elimination reactions and thus their
death through apoptosis. Indirect, genomic mechanisms of toxic- biotransformation and biodegradation reactions are limited and are
ity involve permanent modification of the transcription of gene mostly confined, albeit to poor yield, only to anaerobic environment
elements by interference at the epigenetic level of DNA functioning. of sludges, but seldom in mammalian organisms. As a consequence,
Since little is known on the relationship among events that their interaction with biological systems is mostly limited to ago-
result in OCPs’ toxicity in humans (Mortensen and Euling, in press), nistic or antagonistic binding to the intracellular receptors for
a number of studies are currently ongoing to investigate mecha- which natural hydrophobic substances, such as steroid derivatives,
nisms responsible for OCPs’ toxicity. A better knowledge on how are the endogenous ligands. Agonistic binding leads to recruit-
these compounds influence the development and progression of ment of coactivators and thus increases transcriptional activity
diseases is a crucial step towards addressing the emerging dis- while antagonistic binding prevents coactivator recruitment and/or
eases and hence improving public health. In this review, we provide attracts corepressors, leading to decreased transcriptional activity
an overview on available information of possible mechanisms of of the receptors.
toxicity of some selected OCPs and where possible a linkage is Many POPs including OCPs are known or suspected to be
made to epidemiological data. We summarize findings of epidemi- endocrine active. When present in the body they may interfere
ological studies and both in vitro and in vivo experimental studies at several control points in the hormone signaling pathways. As
(Tables 1–3). a result, the response cascade of natural hormones can either be
The main OCPs for which we review available information inhibited or excessively enhanced, at the wrong time, in the wrong
are dichlorodiphenyl-trichloroethane (DDT) and its metabolites, tissue (Swedenborg et al., 2009). Endocrine activity of OCPs can be
hexachlorobenzene (HCB), beta-hexachlorohexacyclohexane (- due to direct binding with hormone receptors due to their confor-
HCH) and endosulfan. These chemicals have been employed in mational similarity with the receptor-binding portions of natural
agriculture and in public health as insecticides and biocides for hormones, mainly of the steroid and diphenylether (thyroxine)
several decades but were mostly banned between the ‘1970 and structural groups. This is the case of aromatic polychlorinated sub-
1990s’. Only a few active substances, essentially DDT is still used stances such as DDT and its structural cognates, endosulfan and
in tropical countries to control malaria vectors through indoor lindane. Other compounds indirectly alter hormonal pathway by
residual spraying (Bouwman et al., 2011) and lindane for treat- directly inhibiting enzyme activities responsible for biosynthesis
ment of lice and scabies (Engeler, 2009). So, most exposures of the precursors of steroid hormones. In particular, the DDT ana-
derive from past uses and, in certain cases, are still significant log, mitotane, a pharmaceutical drug which is used to suppress
because of the long persistence and biomagnification of these cortisol production also causes a sharp raise in plasma cholesterol compounds. levels.
76 E.J. Mrema et al. / Toxicology 307 (2013) 74–88
Table 1
Summary for selected epidemiological studies showing the relationship of DDT/DDE exposure and health-related effects.
Author Effects assessed OCP measured OCP level OCP level (g/g Results ptrend
(g/L serum) lipid serum)
Cohn et al. (2007) Breast cancer DDT Tertiles Tertiles OR, 95% CI
<8.09 <1.1 1.00 0.01
8.09–13.9 1.1–1.8 2.8 (1.1–6.8)
>13.9 >1.8 5.4 (1.7–17.1)
–
McGlynn et al. (2006) Liver cancer DDT Quintiles OR, 95% CI
<0.265 1.00 0.049
0.265–0.382 1.3 (0.7–2.5)
0.383–0.521 1.4 (0.7–2.6)
0.522–0.787 1.4 (0.7–2.7)
>0.787 2.0 (1.1–3.9)
–
McGlynn et al. (2006) Liver cancer DDT adjusted for DDE level Quintiles OR, 95% CI
<0.265 1.00 0.0024
0.265–0.382 1.5 (0.8–2.7)
0.383–0.521 1.7 (0.9–3.3)
0.522–0.787 1.4 (1.0–4.3)
>0.787 2.0 (1.7–8.6)
–
McGlynn et al. (2008) Testicular germ tumors DDE Quartiles RR, 95% CI
≤0.157 1.00 0.0002
0.158–0.250 1.01 (0.75–1.36)
0.251–0.390 1.00 (0.73–1.38)
>0.390 1.71 (1.23–2.38)
2.1.1. Interference of OCPs in estrogen hormone metabolism DDT. In fact, the concentration of DDT employed in the Bradlow
−5

17 -Estradiol is the main estrogen hormone, responsible for experiments is 10 M (10 M), while the physiological concen-
development of female sex characteristics such as growth of tration of steroid hormones such as estradiol is of at least four to
the breasts and suppression of body hair growth. Biotransfor- six orders of magnitude lower (low-picomolar). On the other hand
mation of 17-estradiol proceeds via two common metabolic DDT and its metabolites as well as many other OCPs are known
pathways yielding catechol estrogen 2-hydroxyestrone (2-OHE), phenobarbital-type cytochrome P450 inducers as they have been
a weak estrogen; and 16␣-hydroxyestrone (16␣-OHE), a fully shown to induce cytochrome P450 2B (CYP 2B) in rat liver or cul-
potent estrogen. Enzymes CYP1A1, CYP1B1, CYP1A2 and catechol- tured rat hepatocytes (Campbell et al., 1983; Li et al., 1995; Lubet
O-methyltransferase (COMT) are responsible for this metabolism. et al., 1990, 1992; Yoshioka et al., 1984). The enzyme activation
␣
16 -OHE, but not 2-OHE increases unscheduled DNA synthesis, upon exposure to these pesticides can thus lead to alterations in
uncontrolled cell division and increased anchorage-independent the endogenous levels of hormones and consequently compromise
growth. Interrupting these pathways might lead to formation of hormone signaling. In addition to xenobiotics metabolism, CYP1A1
more potent products as exemplified by some xenoestrogens. has been shown to participate in the activation of dietary polyphe-
Exposure of cell cultures of MCF-7 to concentrations as low as nols (Androutsopoulos et al., 2008, 2009a) and it is inhibited by
−5
10 M of various OCPs such as DDT, lindane, chlordecone and various polyphenolics (Androutsopoulos et al., 2010, 2011).
endosulfan blocked the 2-OHE pathway and increase levels of 16␣-
OHE in estrogen positive (ER+) cells (Bradlow et al., 1995). This 2.1.2. DDT and DDT metabolites
␣
interference in estrogen biotransformation led to increasing 16 - DDT is produced as a technical mixture of 3 isomeric forms, the
OHE/2-OHE ratio relative to the ratio in the untreated control cell most prevalent being the p,p -isomer; o,o - and o,p -being present in
cultures. This increasing ratio has been associated with breast and minor and variable amounts. DDT was initially used in public health
other cancers of animals (Telang et al., 1992) (Fig. 1); possibly control of lice and malaria mosquitoes during the Second World
␣
because of 16 -OHE has a strong estrogenic activity (Bradlow et al., War and afterwards it was used as pesticide in agriculture. Globally
␣
1995). Levels of 16 -hydroxylation have been found increased by DDT production was ∼1.8 million tonnes since 1940s (ATSDR, 2002)
about 50% in human breast cancer as compared to control cases and more than 40,000 tonnes were used in agriculture annually
(Schneider et al., 1982). (Geisz et al., 2008). It is estimated 600,000 tonnes of DDT were
CYP1A1 metabolizes estradiol and environmental contami- used domestically in USA 30 years prior to its ban. Over 80% of
nants into the corresponding hydroxylated derivatives through the the quantity of the pesticide used in 1970–1972 was applied to
highly reactive intermediates of arene-oxide connectivity (Hayes cotton crops and the remainder was used on peanut and soybean
et al., 1996). The expression of CYP1A1 is regulated by the aryl crops. The global production was reported to drop to 3314 tonnes
hydrocarbon receptor (AhR), a ligand-dependent transcription in 2009; the production is meant for use in control of malaria and
factor that activates the transcription of target genes, such as leishmaniasis (UNEP, 2010a).
CYP1A1, CYP1A2, CYP1B1 and oncogenes (Androutsopoulos et al., DDT and its metabolite DDE exhibit hormonal activity in vari-
2009b). DDT and its metabolites are capable of up regulating ous tissues with mechanisms involving the steroidogenic pathway,
CYP1A activity (Van Tonder, 2011). According to Navas et al. (2004) receptor mediated changes in protein synthesis or antiandrogenic
CYP1A inducers have defined structures which make them capable and estrogenic actions. Most of their endocrine effects result from
of binding AhR. DDT has two aromatic rings linked by sp3 carbon the ability to mimic 17--estradiol. o,p -DDT is a well character-
and thus each of the rings can rotate along its single bond with the ized DDT isomer; its intracellular mechanism of action is mediated
C2 carbon. This allows some degree of conformational mobility through the ER pathway (Steinmetz et al., 1996) described in Sec-
and in principle the possibility to bind AhR but the rings cannot lie tion 2.1. It has been shown to bind and activate the ER, to promote
in the same plane, as in the estrogen molecules (Fig. 3). Lack of this the expression of estrogen-dependent genes and to induce prolif-
molecular recognition motif greatly limits the affinity of AhR for eration of ER-competent cells such as breast cancer cells (MCF-7)
E.J. Mrema et al. / Toxicology 307 (2013) 74–88 77
Table 2
Summary of selected in vitro, in vivo and epidemiology studies on the endocrine effects of endosulfan.
Author Study type Study sample/materials Effects investigated Observed effects
6
Soto et al. (1994) In vitro MCF-7 cell culture Cell proliferation potential of Endosulfan was 10 times less potent than
pesticides 17-estradiol. Effects observed at doses of
10 M endosulfan or greater.
Soto et al. (1995) In vitro MCF-7 cell culture Relative binding affinity of Endosulfan hPR receptor binding affinity was
5
pesticides 10 less than 17-estradiol.
5
Wade et al. (1997) In vitro MCF-7 cell culture Cell proliferation potential of Endosulfan was 10 less potent as compared to
pesticides 17-estradiol. Effect observed at the highest
soluble dose.
Sinha et al. (1999) In vitro Rat testicular cells in culture Cell viability and lactate Endosulfan produced cytotoxic change. Effects
dehydrogenase leakage observed at 20 M of endosulfan at or above.
Sinha et al. (2001b) In vitro Rat testicular cells in culture Activity of polyol pathway Increased aldose reductase activity and
enzymes decreased sorbitol dehydrogenase activity at
or >20 M of endosulfan.
Grunfeld and In vitro MCF-7 BUS cells Human ER␣ and ER mRNA Endosulfan decreased human ER␣ mRNA
Bonefeld-Jorgensen expression levels weakly with no effect on human EB
(2004) expression.
Li et al. (2006) In vitro MCF-7 cell culture Activation of MAPK, PI3-K, At 20–75 M endosulfan activated P13-K and
PKC, PKA and CaMKIV MAPK. The effect observed at 10 nM of
17-estradiol and DES.
Sinha et al. (1995) In vivo Adult Druckrey rats Testicular enzyme activities, Increased testicular enzyme activities at all
administered with repeat sperm count, sperm doses tested; sperm count decreased in a
dose of endosulfan (0, 2.5, 5 morphology, and dose-dependent manner; decreased spermatid
or 10 mg/kg, 5 days per week intra-testicular spermatid counts and reduced daily sperm production at
for 70 days) count the two highest test doses was reported.
Sinha et al. (1997) In vivo Weanling Druckrey rats Testicular enzyme activity, No observed effects on testes weights;
administered with repeat testes weights, sperm count, increased levels of testicular enzyme activity;
dose of endosulfan (0, 2.5, 5 sperm abnormality, sperm count decreased in a dose-dependent
or 10 mg/kg, 5 days per week spermatid count and daily manner; decreased spermatid count and
for 90 days) sperm production sperm production rate.
Raizada et al. (1991) In vivo Ovariectomized Wistar rats Organs weights, glycogen No effects on weights of uterus, cervix, vagina
administered with repeat content of organs, and and pituitary; no effects on glycogen content of
dose of endosulfan histopathological changes in the organs examined; no histopathological
(1.5 mg/kg daily for 30 days organs changes reported.
and injected daily with
estradiol 1 g/rat i.p.)
Shelby et al. (1996) In vivo Mice administered with Competitive binding of No competitive inhibition of estrogen receptor
repeat dose of endosulfan on endosulfan to mouse observed; no increase in uterine wet mass;
postnatal days 17–19 at a estrogen receptor and DES and estradiol significantly affected uterine
dose of 10 mg/kg uterine growth growth.
Wade et al. (1997) In vivo 18 days rats injected with Uterine estrogen receptor Estradiol binding inhibited at high doses
5
3 mg/kg/day endosulfan daily binding (10 M endosulfan); no change in uterine
for 3 days weights, uterine peroxidase activity or
numbers of uterine estrogen and progesterone
receptors.
Saiyed et al. (2003) Cohort Male children lived in the SMR assessment; serum Sexual maturity delayed in the exposed
village sprayed with testosterone, LH, and FSH; population; controlled for age, only serum LH
endosulfan and children who and endosulfan residues in levels differed between the populations.
lived in 20 km away from blood
village
Ibarluzea et al. (2004) Case–control Breast cancer women (cases) Relationship between cancer Endosulfan residues were not associated with
and non-cancer women diagnosis and the adipose increased risk of breast cancer
(controls) pesticides
Abbreviations: PI3-K, phosphatidylinositol-3-kinase; PKC, protein kinase C; PKA, protein kinase A; CaMKIV, calcium calmodulin-dependent kinase IV; AI, apoptotic index;
MCF-7, Michigan Cancer Foundation-7; SMR, sexual maturity rating; LH, luteinizing hormone; FSH, Follicle Stimulating Hormone; i.p., intraperitoneal injection; ER, estrogen
receptor; hPR, human progesterone; DES, diethylbestrol.
in vitro (Soto et al., 1995). At 10 M concentration, o,p -DDT ago- promoter with a luciferase reporter vector revealed that androgen-
␣
nized both ER - and ER-mediated transcription a potency that is induced AR transcriptional activity was inhibited by p,p -DDE or by
approximately 0.1% that of estradiol (Lemaire et al., 2006). A signif- the potent antiandrogen, hydroxyflutamide at 0.2 M (63.6 ppb)
icant dose-dependent increase in cell number in MCF-7 cell culture concentration. This level of p,p -DDE is lower than 140 ppb found
−8
was observed starting at 10 M and maximum response achieved among residents living in DDT-treated homes (Bouwman et al.,
−6
at 10 M (Steinmetz et al., 1996). Enantiomer-specific estrogenic 1991). In utero exposure to DDE has been shown to decrease
activity has been suggested (Hoekstra et al., 2001; McBlain, 1987; anogenital distance (a morphologic quantitative indicator of fem-
−5
Wang et al., 2009). At 5.26 × 10 M (S)-(−)-o,p -DDT produced half inization of male offspring) in male rat offspring, to increase
of the maximum effect (EC50) whereas (R)-(+)-o,p -DDT had negli- retention of male nipple and to cause an alteration in expression of
gible estrogen activity (Hoekstra et al., 2001). The (+)-enantiomer androgen receptor (Kelce et al., 1995) suggesting that these abnor-
exhibited estrogen-like response only at an environmentally unre- malities might be mediated at the level of the androgen receptor.
−3
alistic concentration of 10 M, and thus estrogenic activity of In addition to anti-androgen activity, p,p -DDE can activate the
o,p -DDT is due to the (−)-enantiomer. ER and induce cell proliferation (Kelce et al., 1995). 17-Estradiol
−8 −5 −5
Transient cotransfection assay of monkey kidney CV1 cells with (1 × 10 M), o,p -DDT (1 × 10 M) and -HCH (1 × 10 M) sim-
human AR expression vector and a mouse mammary tumor virus ilar showed gene expression profile of estrogen-responsive genes
78 E.J. Mrema et al. / Toxicology 307 (2013) 74–88 B at by
The of in ROS
in
M. B these vitro ROS
p38
higher
cellular this NF- groups;
MDA MDA cells
group bak group;
in
SP600125,
by
on
Bak The
30 MDA
NAC;
M elevated M M and NF- M;
the the leakage for
NAC;
significant
and groups;
effect.
were
and caspase-3 germ nuclear
in
dehydrogenase; increased
over increased
50 PBMC with higher by
no
effect neutralized 50 50 attenuated
increase
membrane
FasL
rescued
of LDH A
in induced bax effect. case higher
a
this observed,
at
>30-
b.wt
or
a
Bax in
D; in manner.
c,
inhibitor;
time-dependent methoxychlor. FasL, increased p65 time-dependent
in
and and and
at time-dependent
in
little 30 the a
and NAC B any
A mRNA
of
50;
A cells.
NAC;
and M lactate
JNK2
human 30
doses attenuated in apoptosis lindane. p38
in
groups; Fas,
blocked
h.
3 increased or
mg/kg h. respectively;
groups, had
% by of was 6 in
of
of 6 basement NF- group
all have
attenuated higher
dose 50
and increase
30
M,
and all germ decreased NAC phosphorylation
as
LDH,
100 extract attenuated as M in the
cytosol, cells
tested
the NAC by
This
not degeneration in
of
increased
dose
and 10,
level cytochrome
antinomycin
B; NAC;
caspase-8 to
significantly
10 group.
time-dependent JNK1
all Caspase
cells and significantly
M. levels
JNKs
and single
50
enhanced NAC early
decreased
did early Fas. SB202190,
A by
near a
of
germ time-dependent apoptosis
increased cells
B
induced in 60
as with
and
lower as a activity and
with NAC; b.wt neutralized
single
and group
50
mRNA b.wt; in induced and nucleus
kappa group;
a
in blood 30
selective children. progressively.
mRNA
treatments, by after
or
FasL group,
treated
Fas
significantly NF-
cytoplasmic
to
and reduced leakage -DDE M to
SOD p38
region
M M M -BHC of 30 p -3
production in
mg/kg ,
induced inhibited
-8
over
SP600125
observed.  DDD
death activity induced FasL
mg/kg
p
elevated
apoptotic translocation
elevated factor NAC.
50 LDH
m activity; 9 c 70
M D; NAC;
50 50
and group 100
lower of
activated
M; ROS
with and manner and
groups;
significantly
cell
weights; caspase-3 mononuclear; neutralized and
level
by
>20
M, dosage.
SOD
inhibited or increased
in
-DDD
or
and in M TUNEL-labeled